Active surveillance of prostate cancer leads to improved quality of life
the ONA take:
Prostate cancer is usually a slow-growing cancer. As a result, many men can opt to delay or avoid undergoing treatment. The process, referred to as active surveillance, allows men with prostate cancer to delay or avoid the side effects of its treatment as well.
Although the side effects of prostate cancer treatment can affect quality of life, the impact active surveillance has on quality of life is questionable. In this study, researchers found 10 previous studies that examined quality of life and other psychological issues related to men coping with prostate cancer.
The studies included 966 men with prostate cancer, all of whom chose active surveillance over aggressive treatment.
The results of this review show that quality of life scores for men who chose active surveillance were similar to the scores for men who chose surgery. Anxiety, depression, and general distress scores also were not worse in the active surveillance group.
The researchers conclude that although men who opt for active surveillance do not experience worse quality of life, they should still be assessed for potential problems and offered support as needed.
Active surveillance allows men with prostate cancer to delay or avoid the side effects of its treatment as well.
Additionally, the men who decided to track their cancers in a process known as "active surveillance" did not appear to suffer added emotional stress, researchers found. "The men in our study did not appear to suffer from any major negative psychological impacts, including anxiety and depression," said Dr. Lara Bellardita, the study's lead author from the IRCCS Foundation's National Cancer Institute in Milan, Italy.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|